New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia ...
For patients with both rheumatoid arthritis (RA) and type 2 diabetes (T2D), interleukin-1 (IL-1) inhibition with anakinra (Kineret, Biovitrium AB), a human IL-1 receptor antagonist, was more effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback